Lee's Pharmaceutical Holdings (HKSE:00950) Dividend Payout Ratio : 0.09 (As of Jun. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Lee's Pharmaceutical Holdings Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Lee's Pharmaceutical Holdings's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.09.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's Dividend Payout Ratio or its related term are showing as below:

HKSE:00950' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.02 Med: 0.28 Max: 0.86
Current: 0.19

During the past 13 years, the highest Dividend Payout Ratio of Lee's Pharmaceutical Holdings was 0.86. The lowest was 0.02. And the median was 0.28.

HKSE:00950's Dividend Payout Ratio is ranked better than
81.9% of 442 companies
in the Drug Manufacturers industry
Industry Median: 0.37 vs HKSE:00950: 0.19

As of today (2025-03-30), the Dividend Yield % of Lee's Pharmaceutical Holdings is 2.03%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Lee's Pharmaceutical Holdings was 4.42%. The lowest was 0.53%. And the median was 1.63%.

Lee's Pharmaceutical Holdings's Dividends per Share for the months ended in Jun. 2024 was HK$0.01.

During the past 12 months, Lee's Pharmaceutical Holdings's average Dividends Per Share Growth Rate was -10.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -34.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -28.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -9.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Lee's Pharmaceutical Holdings was 36.20% per year. The lowest was -34.80% per year. And the median was 12.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Lee's Pharmaceutical Holdings Dividend Payout Ratio Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Dividend Payout Ratio Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dividend Payout Ratio

Get a 7-Day Free Trial

0.27

0.02

0.29

0.86

0.16

Lee's Pharmaceutical Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Dividend Payout Ratio	Get a 7-Day Free Trial															0.11	0.37	8.00	0.09	0.39

Competitive Comparison of Lee's Pharmaceutical Holdings's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lee's Pharmaceutical Holdings's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's Dividend Payout Ratio falls into.

Save Embed

;

Save Embed

;

Lee's Pharmaceutical Holdings Dividend Payout Ratio Calculation

Lee's Pharmaceutical Holdings's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0.018	/	0.021
	=	0.86

Lee's Pharmaceutical Holdings's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2024 )	/	EPS without NRI (Q: Jun. 2024 )
	=	0.01	/	0.106
	=	0.09

Lee's Pharmaceutical Holdings (HKSE:00950) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Lee's Pharmaceutical Holdings Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (HKSE:00950) » Definitions » Dividend Payout Ratio

Traded in Other Exchanges

N/A

Address

Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Executives

Lion River I N.v.	2201 Interest of corporation controlled by you
Li Zhenfu	2201 Interest of corporation controlled by you
Assicurazioni Generali Spa	2201 Interest of corporation controlled by you
Leelalertsuphakun Wanee	2101 Beneficial owner
Huang Zuie-chin	2201 Interest of corporation controlled by you
Lue Shuk Ping Vicky	2202 Interest of your spouse
Li Xiaoyi	2101 Beneficial owner
Lee Siu Fong	2101 Beneficial owner
Ubs Group Ag	2201 Interest of corporation controlled by you
Panacea Venture Healthcare Fund Ii, L.p.	2101 Beneficial owner
Panacea Innovation Limited	2201 Interest of corporation controlled by you
Guang Dong Min Ying Tou Zi Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Apta Finance Sa	2201 Interest of corporation controlled by you
Qualister Sa	2101 Beneficial owner
Paponi Claudia	2202 Interest of your spouse

Lee's Pharmaceutical Holdings Headlines

No Headlines